Bhatia Sangeeta N.'s Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed May 3, 2023
- Accession no.
- 0001209191-23-026991
- Filed
- May 3, 2023
- Trade date
- May 1-2, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions. Open-market sales total $202.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bhatia Sangeeta N.CIK 0001643921 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2023 | Common Stock | AGrant or awardAcquired | +1,168 | $0.00 | $0 | 5,208 | Direct | |
| May 2, 2023 | Common Stock | SSaleDisposed | −62 | $345.93F3,F4 | −$21,447.66 | 5,146 | Direct | |
| May 2, 2023 | Common Stock | SSaleDisposed | −172 | $346.69F3,F5 | −$59,630.68 | 4,974 | Direct | |
| May 2, 2023 | Common Stock | SSaleDisposed | −120 | $348.16F3,F6 | −$41,779.2 | 4,854 | Direct | |
| May 2, 2023 | Common Stock | SSaleDisposed | −163 | $349.82F3,F7 | −$57,020.66 | 4,691 | Direct | |
| May 2, 2023 | Common Stock | SSaleDisposed | −63 | $351.20F3,F8 | −$22,125.6 | 4,628 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 5 transactions in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $345.93 (range $345.20 to $346.12).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $346.69 (range $346.31 to $347.03).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $348.16 (range $347.91 to $348.64).
Referenced by the price of 1 transaction in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $349.82 (range $349.17 to $350.08).
Referenced by the price of 1 transaction in Table I.
- F8
Open market sales reported on this line occurred at a weighted average price of $351.20 (range $350.92 to $351.48).
Referenced by the price of 1 transaction in Table I.